China Medical Technologies Reports Second Fiscal Quarter Financial Results

China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China -based advanced in-vitro diagnostic ("IVD") company, announced its unaudited financial results for the second fiscal quarter ended September 30, 2011 ("2Q FY2011") today.

2Q FY2011 and Six Months Ended September 30, 2011 Highlights

FONAR Announces 1st Quarter Fiscal 2012 Financial Results as Net Income Increases 360% to $1.8 Million

FONAR Corporation (NASDAQ: FONR - News), The Inventor of MR Scanning™, reported today its first quarter of fiscal 2012. The Company reports net income has risen 360% to $1.8 million for the first fiscal 2012 quarter ended September 30, 2011 from $363 thousand one year earlier for the fiscal quarter ended September 30, 2010. The Company has net income for the past six quarters and income from operations for the past seven quarters.

Statement of Operations Items
Total revenues increased 11% to $9.6 million for the quarter ended September 30, 2011, from $8.7 million for the corresponding quarter which ended one year earlier on September 30, 2010.

Align Technology Announces $150 Million Stock Repurchase Program

Align Technology, Inc. (Nasdaq:ALGN - News) today announced that its board of directors has authorized a stock repurchase program of up to $150 million, effective immediately.

"Our strong balance sheet and healthy cash flow enable the company to return excess cash to our shareholders through a share repurchase program while continuing to invest in our strategic growth initiatives. It will also help offset dilution from our employee equity plans," said Ken Arola, vice president and chief financial officer of Align Technology. "The Board of Directors believes that our stock represents an attractive investment for Align and its investors and the repurchase program demonstrates the company's ongoing commitment to increasing shareholder value."

ZELTIQ Aesthetics, Inc. Prices Initial Public Offering

ZELTIQ® Aesthetics, Inc. (NASDAQ:ZLTQ - News), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the pricing of its initial public offering of 7,000,000 shares of its common stock at a price of $13.00 per share. The shares are expected to begin trading on October 19, 2011 on The NASDAQ Global Select Market under the ticker symbol "ZLTQ." ZELTIQ is offering 6,693,000 shares and selling stockholders are offering the remaining 307,000 shares. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,050,000 shares of common stock from ZELTIQ to cover over-allotments, if any.